Cannabis Law Report
JULY 23, 2019
Businesses preparing to market a new product nationally must follow the rules of trademark law as well as marketing and advertising claims under state and US laws when creating a trademark, advertising copy and copyright-registered packaging for the product. This is particularly the case for cannabis and cannabidiol (CBD) products.
Cannabis Law Report
JUNE 4, 2021
We believe there is a benefit to Delta-8 but there should be labeling or warnings on packages so that consumers are informed of potential minor intoxication effects. With no research or clinical trials conducted on the effects of consuming these compounds, there is an elevated amount of risk selling Delta 8-THC products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
OCTOBER 19, 2021
A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment.
Otherside Farms
JANUARY 16, 2019
Scientists have been answering these questions in several clinical trials already, particularly on the effects of microdosing at treating some common medical issues, such as pain, anxiety, depression, insomnia, and others. In fact, some methods of consumption make accurate dosing impossible. However, does it really work?
Cannabis Law Report
MARCH 29, 2020
o Technology powered research: Virtual clinical trials and other accelerated technologies that mix the potential of new technologies with cannabis to create research insights quickly and more accurately, are being classified as Cannabis 3.0, triggering new innovations and improved data quality through better user experiences.
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. References. 30 (2): 187–96.(1998).
Expert insights. Personalized for you.
40 
Let's personalize your content